Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • XYZ vs GSK✓SelectedUSD · GSKXYZ vs GSK performance historyLatest closeAs of-1.92%11/16
Stock and ETF performance explorer

XYZ vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+589.0%
GSK return
+107.3%
Excess return
+481.7%
Maximum drawdown
-86.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.9%-0.1%-1.8%-1.9%
7D-6.3%-1.3%-5.0%-5.8%
30D+6.5%+2.7%+3.8%+5.5%
3M+0.1%+2.7%-2.6%-1.1%
6M+17.9%+3.3%+14.6%+15.5%
YTD+27.5%+6.5%+21.0%+22.3%
1Y+37.2%+10.7%+26.5%+29.2%
3Y+47.4%+64.4%-16.9%+6.6%
5Y-65.2%+46.7%-111.9%-73.5%
10Y+589.0%+109.4%+479.7%+324.5%
All+589.0%+107.3%+481.7%+324.5%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling